November 16, 2022 By Jim Hammerand Why Affera’s cardiac ablation technology is worth $1B to Medtronic
November 8, 2022 By Jim Hammerand What’s next for Medtronic RDN after Symplicity Spyral trial ‘surprise’?
August 16, 2022 By Jim Hammerand What Laura Mauri learned from a ‘firestorm’ in her first months at Medtronic
August 1, 2022 By Jim Hammerand Medtronic’s Design for Reliability and Manufacturability after the reorganization
May 26, 2022 By Jim Hammerand ‘Catastrophic explosion’ and resin shortage led Medtronic’s supply chain problems
